Author

J. T. Rutherford

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Organism:C. elegans· 1 Research Focus:drug response / drug discovery· 1 Assay:metagenomics· 1

Frequent Co-Authors

C. Dureja· 2 shared A. Deshpande· 1 shared A. M. McKelvey· 1 shared A. O. Olaitan· 1 shared D. Sun· 1 shared F. B. A. Pavel· 1 shared I. Prah· 1 shared J. G. Hurdle· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Dureja

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) Inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy

C. Dureja, J. T. Rutherford, F. B. A. Pavel, K. Norseeda, I. Prah, D. Sun, K. E. Hevener, J. G. Hurdle

This study evaluates the in vivo efficacy of phenylimidazole 296 against C. difficile by targeting CdFabK, showing it retains microbiome stability better than vancomycin and fidaxomicin.

bioRxiv · Sep 22, 2023 · PreprintMicrobiology

The Ferrous Iron Transporter FeoB1 is Essential for Clostridioides difficile Toxin Production and Pathogenesis in Mice

A. Deshpande, C. Dureja, A. M. McKelvey, W. Zhao, J. T. Rutherford, A. O. Olaitan, J. Hurdle

This study shows that FeoB1 is critical for C. difficile toxin production and virulence, suggesting it as a therapeutic target for CDI.

bioRxiv · Mar 3, 2022 · PreprintMicrobiology